Partial trisomy 9p syndrome: Expanding the phenotype
DOI:
https://doi.org/10.5281/zenodo.10713116Keywords:
Karyotype, Congenital, Heart Defects, Human, Chromosomes, TrisomyAbstract
Background: Trisomy of the short arm of chromosome 9 (9p) is the fourth most common chromosomopathy. It is a partial or complete autosomal structural anomaly of the short arm of chromosome 9. It is generally caused by a reciprocal parental translocation between chromosome 9 and another autosome; spontaneous genetic alteration (de novo) is rare. It presents great phenotypic variability due to the variable size of the chromosome fragment involved.
Clinical case: We present the case of a patient diagnosed with trisomy of the short arm of chromosome 9 with a karyotype with a chromosomal complement 46,XX,add(9)(p24), interpreted as an additional chromosome fragment on chromosome 9p. A microarray study was carried out, which reported that the 9p24.3-p13.1 region is found in triple dose, which corresponds to a partial trisomy 9p or Rethoré syndrome, which is a low prevalence entity, with an expressiveness and variable prognosis. In the present case, the finding of a murmur and diagnosis of pulmonary valve stenosis was the initial approach; The heart disease described in our patient has not been reported in the literature as part of the clinical picture, meaning that it was not an initial diagnostic suspicion.
Conclusion: Despite having described an already defined phenotype, other clinical data that are not documented should be considered, and when new clinical evidence is found, report it and thereby expand the phenotype for a timely diagnosis.
Downloads
References
Dhangar S, Korgaonkar S, Vundinti BR. Partial trisomy 9 (9pter->9q22.1) and partial monosomy 14 (14pter->14q11.2) due to paternal translocation t(9;14)(q22.1;q11.2) in a case of dysmorphic features. Intractable Rare Dis Res. 2019;8(1):72-7.
Pazmiño-Miranda AM, Carvajal-García MF, Velastegui-Ayala EM, et al. Trisomía 9: primer caso clínico neonatal reportado en el Ecuador. Pediatria. 2023;56(1):1-4.
Luna-Barrón B, Taboada-López G, Siacar-Bacarreza S, et al. Trisomía 9: Reporte de un caso. Cuadernos. 2019;60(1):37-40.
Vaglio A, Búrix B, Quadrelli A, et al. Síndrome de trisomía 9p: características. Seguimiento de doce años. Arch Pediatr Urug. 2007;78(2):151-6.
Cammarata-Scalisi F. Trisomía 9p. Una breve descripción clínica, diagnóstica y terapéutica. Arch Argent Pediatr. 2019;117(5):473-6.
Mohamed AM, Kamel AK, Eid MM, et al. Chromosome 9p terminal deletion in nine Egyptian patients and narrowing of the critical region for trigonocephaly. Mol Genet Genomic Med. 2021;9(11).
Alfi O, Donnell G, Allderdice P, et al. The 9p- syndrome. Ann Genet. 1976;19(1):11-6. doi: 10.1136/jmg.16.1.75.
Brambila-Tapia AJ, Neira VA, Vásquez-Velásquez AI, et al. Pure 9p trisomy derived from a terminal balanced unreciprocal translocation. Genetic Counseling. 2014;25(3):289-97.
Stagi S, Lapi E, Seminara S, et al. Long-term auxological and endocrinological evaluation of patients with 9p trisomy: a focus on the growth hormone-insulin-like growth factor-I axis. BMC Endocr Disord. 2014;14(3):1-10. Disponible en: http://www.biomedcentral.com/1472-6823/14/3.
Canton APM, Nishi MY, Furuya TK, et al. Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature. Am J Med Genet A. 2016;170(4):1046-9.
Kuan CY, Tai CJ, Shyu IL, et al. A de novo partial trisomy 9p with Dandy-Walker malformation and ventriculomegaly. Taiwan J Obstet Gynecol. 2022;61(6):1077-81.
Littooij AS, Hochstenbach R, Sinke RJ, et al. Two cases with partial trisomy 9p: Molecular cytogenetic characterization and clinical follow-up. Am J Med Genet. 2002;109(2):125-32.
Henningsen MB, Gulisano HA, Bjarkam CR. Congenital hydrocephalus in a trisomy 9p gained child: a case report. J Med Case Rep. 2022;16(1).
Abdallah-Bouhjar IB, Hannachi H, Mougou-Zerelli S, et al. Array-CGH study of partial trisomy 9p without mental retardation. Am J Med Genet A. 2011;155(7):1735-9.
Huret JL, Leonard C, Forestier B, et al. Eleven new cases of del(9p) and features from 80 cases. Journal of Medical Genetics. 1988;25:741-9. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1652-67762019000100006&lng=es.
Lengyel A, Kosik A, Pinti É, et al. Trisomy 9p and clinical heterogeneity: Case report of an unusual presentation. Orv Hetil. 2018;159(47):1994-2000.
Temtamy SA, Kamel AK, Ismail S, et al. Phenotypic and cytogenetic spectrum of 9P trisomy. Genetic Counseling. 2007;18(1):29-48.
Juan Xie, Jianlin Z, Yimei Y, et al. Diagnosis of a case with partial 9p trisomy by next generation sequencing. Chin J Med Genet. 2018;35(6):852-5.
Sams EI, Ng JK, Tate V, et al. From karyotypes to precision genomics in 9p deletion and duplication syndromes. Human Genetics and Genomics Advances. 2022;3(1).
Jelin A, Perry H, Hogue J, et al. Clefting in trisomy 9p patients: Genotype-phenotype correlation using microarray comparative genomic hybridization. Journal of Craniofacial Surgery. 2010;21(5):1376-9.
Al Achkar W, Wafa A, Moassass F, et al. Partial trisomy 9p22 to 9p24.2 in combination with partial monosomy 9pter in a Syrian girl. Mol Cytogenet. 2010;3(18). Disponible en: http://www.molecularcytogenetics.org/content/3/1/18.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Médica del Instituto Mexicano del Seguro Social
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.
